Dachaigh › COPD › South Carolina
Sgrùdaidhean clionaigeach COPD ann an South Carolina
Tha 14 sgrùdaidhean airson COPD a’ lorg phàirtichean aig làraichean ann an South Carolina.
Bailtean ann an South Carolina
Teacsa sgrùdaidh oifigeil (Beurla)
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Spartanburg
- GSK Investigational Site, Union
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06961214Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, Greenville
- GSK Investigational Site, Rock Hill
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Anderson
- Research Site, Charleston
- Research Site, Gaffney
- agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- MedTrial- Site Number : 8400010, Columbia
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Clinical Research of Rock Hill, Rock Hill
A’ fastadhÌre 2
Aoisean 40 gu 85 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- AnMed Oglesby Center- Site Number : 8400074, Anderson
- MD First Research - Lancaster- Site Number : 8400102, Lancaster
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Lancaster
- Research Site, Spartanburg
A’ fastadhÌre 2
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Rock Hill
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Anderson
- Research Site, Columbia
- Research Site, Gaffney
- agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06878261A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Bogan Sleep Consultants, LLC, Columbia
- Velocity Clinical Research, Gaffney, Gaffney
- Clinical Research of Rock Hill, Rock Hill
- agus 1 a bharrachd
A’ fastadhÌre 2/3
Aoisean 35 gu 80 · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 101, Charleston
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT07555483STRIVE Post-Market Registry Study
- AnMed Health, Anderson
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Greenville
- GSK Investigational Site, Rock Hill
A’ fastadhÌre 3
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT07177339Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Medical University of South Carolina (MUSC), Charleston
- McLeod Health, Florence
A’ fastadhSgrùdadh amharc
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2025 · NCT06122077Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.